Tag: diabetes
Browse all articles tagged with “diabetes”.
4 articles
What Is Semaglutide? A Research Overview
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has become one of the most studied compounds for weight management and metabolic health.
What Is Tirzepatide? A Research Overview
Tirzepatide is a dual GIP/GLP-1 receptor agonist that represents a new class of incretin-based therapeutics for type 2 diabetes and obesity management.
Liraglutide: The First-Generation Daily GLP-1 That Paved the Way
A comprehensive overview of liraglutide (Saxenda/Victoza), the first-generation daily GLP-1 receptor agonist with 97% homology to human GLP-1 that established the foundation for the entire class of incretin-based metabolic therapies.
Pramlintide: The Amylin Analog for Diabetes and Satiety Research
A thorough research overview of pramlintide (Symlin), the synthetic amylin analog FDA-approved for diabetes management. Explore its unique mechanism of slowing gastric emptying, suppressing glucagon, and promoting satiety signaling.
For informational purposes only. Not medical advice. Always consult with qualified healthcare professionals.